Statement Of Income And Retained Earnings

Daito Pharmaceutical Co., Ltd. - Filing #7362493

Concept 2023-06-01 to
2023-11-30
2022-06-01 to
2022-11-30
Statement of income and retained earnings
Statement of income and retained earnings
Operating profit (loss)
2,289,000,000 JPY
2,826,000,000 JPY
Non-operating income
Non-operating income
72,000,000 JPY
49,000,000 JPY
Non-operating expenses
Non-operating expenses
46,000,000 JPY
123,000,000 JPY
Ordinary profit (loss)
2,314,000,000 JPY
2,752,000,000 JPY
Extraordinary income
Extraordinary income
0 JPY
JPY
Extraordinary losses
Extraordinary losses
0 JPY
47,000,000 JPY
Profit (loss) before income taxes
2,315,000,000 JPY
2,705,000,000 JPY
Profit (loss)
1,494,000,000 JPY
1,724,000,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.